possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept)

June 1999

The FDA is warning about a possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept). There are 30 reports of serious infections...including 6 deaths.

Enbrel works by binding tumor necrosis factor (TNF)...a protein that leads to joint pain and inflammation.

The problem is that TNF also helps fight infections.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote